COAGHemab Therapeutics Holdings Inc. Common Stock
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States …
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
Biotech IPO Gains Crush AI Listings With Standout 55% Return (Bloomberg) -- The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeUS Strikes Iran in Escalating Cam | ||
Sector Update: Healthcare Stocks Advance Late Afternoon Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.2% and | MMT Newswires | |